Monoclonal antibodies specific for the native, disease-associated isoform of the prion protein
- PMID: 10507020
- DOI: 10.1016/s0076-6879(99)09010-2
Monoclonal antibodies specific for the native, disease-associated isoform of the prion protein
Abstract
Reviewing the circumstances that have led to the first monoclonal antibody against the disease-associated form of PrP, we consider the availability of PrP knockout mice and recombinant PrP, as well as a reliable conformational screening protocol as being important prerequisites for a successful immunization approach. When considering presenting an antigen to a mouse with the goal of obtaining specific monoclonal antibodies against a misfolded or aggregated form of a host protein, it is desirable to increase the definition of a subtle conformational difference. This can be achieved by immunizing an antigen knockout mouse that has not developed self-tolerance against the respective antigen. Furthermore, if conformational isoforms and/or oligomeric forms of a protein sequence are understood to exist in an equilibrium, high and pure amounts of recombinant protein may increase the likelihood that a particular population of protein conformation passes an antigenic threshold necessary to start an immunogenic response. Pulling out the monoclonal antibodies by correct screening is essential. Screening against the pure misfolded or aggregated protein is often complicated by its poor solubility and hence the ability to immobilize. In the present case, immobilization of disease-associated PrP on nitrocellulose had been established as a conformation-sensitive screening method, allowing to "freeze" PrP in its distinguishable, disease-associated conformation. We are cautious to generalize conclusions of how to assess the generation of monoclonal antibodies against these particular protein isoforms to other diseases of protein misfolding and/or aggregation, but ultimately the present approach may inspire respective experiments.
Similar articles
-
Application of a synthetic phage antibody library (ETH-2) for the isolation of single chain fragment variable (scFv) human antibodies to the pathogenic isoform of the hamster prion protein (HaPrPsc).Hybridoma (Larchmt). 2005 Jun;24(3):127-32. doi: 10.1089/hyb.2005.24.127. Hybridoma (Larchmt). 2005. PMID: 15943559
-
[Production of monoclonal antibodies to the prion protein and their characterization].Bioorg Khim. 2008 Nov-Dec;34(6):754-63. doi: 10.1134/s1068162008060058. Bioorg Khim. 2008. PMID: 19088748 Russian.
-
Generation of antibodies against bovine recombinant prion protein in various strains of mice.Clin Vaccine Immunol. 2006 Jan;13(1):98-105. doi: 10.1128/CVI.13.1.98-105.2006. Clin Vaccine Immunol. 2006. PMID: 16426006 Free PMC article.
-
Generation of antibodies against prion protein by scrapie-infected cell immunization of PrP(0/0) mice.Hybrid Hybridomics. 2003 Aug;22(4):263-6. doi: 10.1089/153685903322328992. Hybrid Hybridomics. 2003. PMID: 14511572
-
Vaccine approaches to prevent and treat prion infection : progress and challenges.BioDrugs. 2008;22(1):45-52. doi: 10.2165/00063030-200822010-00005. BioDrugs. 2008. PMID: 18215090 Review.
Cited by
-
Cryptic peptides of the kringle domains preferentially bind to disease-associated prion protein.J Alzheimers Dis. 2009;16(2):421-31. doi: 10.3233/JAD-2009-0980. J Alzheimers Dis. 2009. PMID: 19221431 Free PMC article.
-
Role of lipid rafts and GM1 in the segregation and processing of prion protein.PLoS One. 2014 May 23;9(5):e98344. doi: 10.1371/journal.pone.0098344. eCollection 2014. PLoS One. 2014. PMID: 24859148 Free PMC article.
-
Antibody to DNA detects scrapie but not normal prion protein.Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1380-5. doi: 10.1073/pnas.0307825100. Epub 2004 Jan 20. Proc Natl Acad Sci U S A. 2004. PMID: 14734804 Free PMC article.
-
Analysis of normal and mutant iduronate-2-sulphatase conformation.Biochem J. 2005 Mar 1;386(Pt 2):395-400. doi: 10.1042/BJ20040739. Biochem J. 2005. PMID: 15500445 Free PMC article.
-
Loss of prion protein leads to age-dependent behavioral abnormalities and changes in cytoskeletal protein expression.Mol Neurobiol. 2014 Dec;50(3):923-36. doi: 10.1007/s12035-014-8655-3. Epub 2014 Mar 7. Mol Neurobiol. 2014. PMID: 24604355
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials